Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

812
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
812
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

695
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
695
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Actuarial Approach01:20

Actuarial Approach

356
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
356

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Quality of Colorectal Cancer Care at Commission on Cancer Accredited Hospitals.

Journal of the American College of Surgeons·2026
Same author

Real-World Outcomes of Radiation After Chemoimmunotherapy for Stage III Lung Cancer.

Clinical lung cancer·2026
Same author

Use of Complementary and Alternative Medicine in the Management of Breast Cancer.

JAMA network open·2026
Same author

Proposed Version Nine of the AJCC and UICC TNM Classification for Salivary Gland Carcinoma.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Surgical Trainee Familiarity and Knowledge of the Commission on Cancer Operative Standards: A National Survey Study.

Journal of the American College of Surgeons·2026
Same author

Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker-driven therapeutics.

CA: a cancer journal for clinicians·2026
Same journal

Breaking the Polytrauma-Brain Barrier: Using Point-of-Care Biomarkers in Severely Injured Trauma Patients.

Journal of the American College of Surgeons·2026
Same journal

Going the Extra Mile: Picking the Right Trauma Center Destination for Critically Injured Patients in a Mature State-Wide Trauma System.

Journal of the American College of Surgeons·2026
Same journal

What Does It Mean for Surgeons to Be Flourishing?

Journal of the American College of Surgeons·2026
Same journal

Tailor-Made Solution to Trimming Venous Thromboembolism Risk.

Journal of the American College of Surgeons·2026
Same journal

NIH Funding in Surgical Artificial Intelligence: Who, What, Where, Why.

Journal of the American College of Surgeons·2026
Same journal

Efficacy and Safety of Rezūm Water Vapor Thermal Ablation in Large and Small Prostates: A Multicenter Comparative Analysis of 2,725 Patients.

Journal of the American College of Surgeons·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

844

Updated Review: Using the National Cancer Database for Outcomes-Based Research.

Oluwaseun F Ayoade1, Giorgio Caturegli1, Bryan Palis2,3

  • 1Division of Thoracic Surgery, Department of Surgery, Yale University School of Medicine, New Haven, CT.

Journal of the American College of Surgeons
|March 18, 2026
PubMed
Summary
This summary is machine-generated.

The National Cancer Database (NCDB) has been updated with more detailed data and faster reporting, improving its relevance for cancer research. Researchers must consider these changes for accurate analysis.

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.7K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Related Experiment Videos

Last Updated: Mar 19, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

844
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.7K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Area of Science:

  • Oncology and Health Services Research
  • Data Science and Biostatistics

Background:

  • The National Cancer Database (NCDB) is a crucial source for cancer outcomes research in the U.S., covering 73.7% of diagnoses.
  • Recent therapeutic and policy shifts necessitate NCDB structural and variable revisions to maintain research relevance.

Purpose of the Study:

  • To characterize major updates to the NCDB over the past decade.
  • To assess the implications of these revisions for cancer research.

Main Methods:

  • A narrative review of NCDB data dictionaries, American College of Surgeons bulletins, and internal updates was conducted.
  • Systematic summarization of structural modifications, variable additions, and policy changes impacting data capture, follow-up, staging, and accessibility.

Main Results:

  • The NCDB now includes over 55 million records from 1,413 hospitals, with near-real-time reporting via the Rapid Cancer Reporting System.
  • Key updates include reduced embargo periods, a 15-year follow-up limit, refined variables (e.g., tumor size, grade, staging), and new data elements (e.g., Medicaid expansion, COVID-19, smoking status).
  • AJCC 8th edition staging was implemented in 2018, with the 9th edition rollout ongoing; planned PD-L1 reporting for lung cancer begins in 2025.

Conclusions:

  • The NCDB has evolved to provide more granular, contemporary, and policy-relevant data while maintaining extensive national coverage.
  • Investigators must carefully consider staging transitions, variable changes, follow-up limitations, and potential biases for valid NCDB-based research interpretation.